Recherche
-
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
(European Journal of Epidemiology. pp. 1-11, 2022-09-21)Article de revue -
Risk of skin ulcer and use of COX-2 inhibitors: A national population-based nested case control study
(European Journal of Clinical Pharmacology, 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), gr, Athènes, 2022-06)Autre communication scientifique (congrès sans actes - poster - séminaire...) -
Use of cardiovascular and antidiabetic drugs during COVID19 epidemic in France
(Fundamental & Clinical Pharmacology. vol. 36, n° S1, pp. 94-95, 2022-06)Article de revue -
Risk of first ischemic stroke and use of antidopaminergic antiemetics: A nationwide case-time-control study
(Fundamental and Clinical Pharmacology. vol. 36, pp. 22-23, 2022-06)Article de revue -
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study
(BMJ. vol. 376, 2022-03-23)Article de revueLibre accès -
Chronic polypharmacy at all age: a population-based drug utilization study
(Fundamental and Clinical Pharmacology. vol. 36, n° 2, pp. 405-413, 2022-04)Article de revue -
Systematic review on sex differences for drug use after stroke
(Fundamental and Clinical Pharmacology. vol. 36, pp. 111-111, 2022-06)Article de revue -
Impact of lockdown in COVID-19 on methadone-use related hospitalizations in France
(Fundamental & Clinical Pharmacology. vol. 36, pp. 37-38, 2022-06)Article de revue -
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
(Diabetes Care, 2022-11-10)Article de revue -
Risk of skin ulcer and use of COX-2 inhibitors: A national population-based nested case control study
(Fundamental and Clinical Pharmacology. vol. 36, pp. 87-88, 2022-06)Article de revue